Ebiowei Samuel F Orubu

Biographic Data

ID6333330
NAMEEbiowei Samuel F Orubu
GIVEN NAMESEbiowei Samuel F
FAMILY NAMEOrubu
SIGNATUREORUBU E S F
AFFILIATIONSNiger Delta University
ORCID0000-0003-4455-5801
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS1
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2016
LATEST PUBLICATION YEAR2025
H-INDEX1

  • Covid-19 impact on AMR

    Open AccessFiona Emdin, Ebiowei Samuel F Orubu et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded existing societal and health inequities. This rapid scoping review examined how three selected healthcare system factors, which we have called 'drivers'-antimicrobial use, infection prevention and control and health system use-were affected by COVID-19 and how they have impacted resistance. METHODS: Peer-reviewed searches…

  • Waves of attention

    Open AccessKristen Overton, Nicolas Fortané et al.ARTICLEBMJ Global Health2021

    This article uses quantitative and qualitative approaches to review 75 years of international policy reports on antimicrobial resistance (AMR). Our review of 248 policy reports and expert consultation revealed waves of political attention and repeated reframings of AMR as a policy object. AMR emerged as an object of international policy-making during the 1990s. Until then, AMR was primarily defined as a challenge of human and agricultural domains…

  • Benchmarking national action plans on antimicrobial resistance in eight selected LMICs

    Open AccessEbiowei Samuel F Orubu, Angel Ramón del Río Aldaz et al.ARTICLEJournal of Global Health2020

    All NAPs were concordant with GAP. However, gaps exist in relation to M&E, diminishing the countries' capacity to be accountable and implement corrective action if necessary. Most lacked financing plans and targets for antimicrobial use reduction. The antimicrobial quality assurances strategies are limited in most of the NAPs assessed. A mechanism by which countries can benchmark their NAP would allow identification of specific limitations and ar…

  • Access to essential cardiovascular medicines for children

    Open AccessEbiowei Samuel F Orubu, Faith O Robert et al.ARTICLEHealth Policy and Planning2019Cited by: 1References: 16

    Policies to improve access to medicines for children in low- and middle-income countries, such as Nigeria, should consider the growing threat of non-communicable diseases. The aim of this pilot study was to scope availability, price and affordability of essential cardiovascular medicines for children in selected states in Nigeria. The study was a descriptive longitudinal survey conducted in three phases. Availability was determined as percentage …

  • Access to age-appropriate essential medicines

    Open AccessEbiowei Samuel F Orubu, Chinyere Okwelogu et al.ARTICLEHealth Policy and Planning2016References: 23

    Policies to improve access to medicines for children in Nigeria do not include compounding as a source of medicines. Compounding is often applied as a last resort in health institutions to provide age-appropriate formulations usually for oral use in young children; but it bears some risk. Some countries have adopted policies aimed at reducing the risk based on available data. There is not much data for Nigeria. This retrospective study examined c…